AR045089A1 - "proceso para la preparacion de inhibidores de la cpla2" - Google Patents

"proceso para la preparacion de inhibidores de la cpla2"

Info

Publication number
AR045089A1
AR045089A1 ARP040102620A ARP040102620A AR045089A1 AR 045089 A1 AR045089 A1 AR 045089A1 AR P040102620 A ARP040102620 A AR P040102620A AR P040102620 A ARP040102620 A AR P040102620A AR 045089 A1 AR045089 A1 AR 045089A1
Authority
AR
Argentina
Prior art keywords
compound
group
alkyl
formula
halogen
Prior art date
Application number
ARP040102620A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR045089A1 publication Critical patent/AR045089A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Reivindicación 1: Un proceso para la preparación de un compuesto de la fórmula (1) en la cual: n es un entero en el rango de 0-10; R1 representa un grupo alquilo C1-10 recto o ramificado o -CH2-fenilo, donde el grupo fenilo tiene optativamente hasta dos sustituyentes independientemente seleccionados del grupo formado por alquilo C1-4, alcoxi C1-4, halógeno y nitrilo, donde cada alquilo y alcoxi está optativamente sustituido con uno al máximo número de átomos de halógeno; cada uno de R2 y R3 es independientemente seleccionado del grupo formado por H, halógeno, nitrilo, alquilo C1-4 y alcoxi C1-4 y R4 representa un grupo alquilo C1-10 recto o ramificado, como se muestra en el grupo de fórmulas (2), donde cada uno de R2a y R3a es independientemente seleccionado del grupo formado por H, halógeno, nitrilo, alquilo C1-4 y alcoxi C1-4 donde dicho proceso comprende: a) la reacción del compuesto R1-SO2Cl con el compuesto HC:::C-(CH2)n-NH2 o una forma de sal del mismo, donde n representa un entero de 0-10, en condiciones alcalinas, para producir el compuesto intermedio de fórmula (3); b) y luego la reacción del compuesto de la fórmula (3) con el compuesto de la fórmula (4).
ARP040102620A 2003-07-25 2004-07-23 "proceso para la preparacion de inhibidores de la cpla2" AR045089A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49000503P 2003-07-25 2003-07-25

Publications (1)

Publication Number Publication Date
AR045089A1 true AR045089A1 (es) 2005-10-12

Family

ID=34115341

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102620A AR045089A1 (es) 2003-07-25 2004-07-23 "proceso para la preparacion de inhibidores de la cpla2"

Country Status (14)

Country Link
US (2) US6891065B2 (es)
EP (1) EP1648861B1 (es)
JP (1) JP4607877B2 (es)
CN (1) CN100577640C (es)
AR (1) AR045089A1 (es)
AT (1) ATE432918T1 (es)
AU (1) AU2004261567A1 (es)
BR (1) BRPI0412904A (es)
CA (1) CA2528174C (es)
DE (1) DE602004021388D1 (es)
ES (1) ES2325265T3 (es)
MX (1) MXPA06000406A (es)
TW (1) TW200510305A (es)
WO (1) WO2005012238A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
TW200510305A (en) 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) * 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
AR053410A1 (es) 2004-08-19 2007-05-09 Wyeth Corp Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos. compuestos intermediarios
GT200600228A (es) 2005-05-27 2006-12-26 Inhibidores de la fosfolipasa a2 citosolica
KR100746342B1 (ko) 2006-04-10 2007-08-03 한국과학기술원 구리 촉매 존재하에서 ｎ―설포닐아미드 화합물의 제조방법
CN100363341C (zh) * 2006-05-12 2008-01-23 北京化工大学 旋光性n-炔丙磺酰胺聚合物及其制备方法
EP2068829A2 (en) * 2006-10-31 2009-06-17 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
CL2007003143A1 (es) * 2006-10-31 2008-01-25 Wyeth Corp Composicion farmaceutica que comprende un compuesto derivado de indol y un sistema portador que comprende 10-50% de un primer solubilizante, 5-50% de un segundo solubilizante, 10-30% de un primer diluyente y 1-15% de un segundo diluyente; proceso de prepracion; y forma de dosificacion.
US8113207B2 (en) * 2008-08-22 2012-02-14 Kimberly-Clark Worldwide, Inc. Self-conforming sound attenuation earplug
CN102617558A (zh) * 2012-03-26 2012-08-01 上海泛凯生物医药科技有限公司 一种维拉佐酮的制备方法
CN110437125B (zh) * 2019-09-06 2021-03-12 苏州旺山旺水生物医药有限公司 一种Tezacaftor中间体II的制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461075A (en) 1988-06-17 1995-10-24 The Procter & Gamble Company Use of vanilloids for the prevention of lesions due to herpes simplex infections
US5186736A (en) 1988-08-02 1993-02-16 Hoechst Aktiengesellschaft Heterocyclic N-acylsulfonamides and their use as herbicides or growth regulators
DE3826230A1 (de) 1988-08-02 1990-02-08 Hoechst Ag Heterocyclische n-acylsufonamide, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als herbizide oder wachstumsregulatoren
JPH02115157A (ja) * 1988-10-24 1990-04-27 Hokko Chem Ind Co Ltd スルホニルグリシン誘導体および除草剤
CA2017383A1 (en) 1989-06-08 1990-12-08 Raymond R. Martodam Use of vanilloids for the treatment of respiratory diseases or disorders
DE3935277A1 (de) 1989-10-24 1991-05-02 Hoechst Ag Sulfonierte heterocyclische carboxamide, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als herbizide oder wachstumsregulatoren
GB9201755D0 (en) 1992-01-28 1992-03-11 British Bio Technology Compounds
CA2179292A1 (en) 1993-12-20 1995-06-29 Roland Andree N-cyanoaryl nitrogen heterocycles with sulphur-containing groupings
DE4431218A1 (de) 1994-09-02 1996-03-07 Bayer Ag Substituierte Pyrimidin(thi)one
DE19528305A1 (de) 1995-08-02 1997-02-06 Bayer Ag Substituierte Phenyluracile
DE19601626A1 (de) 1996-01-18 1997-07-24 Bayer Ag Substituierte N-Aryl-Stickstoffheterocyclen
DE19606594A1 (de) 1996-02-22 1997-08-28 Bayer Ag Substituierte 2-Aryl-1,2,4-triazin-3,5-di(thi)one
WO1998008818A1 (en) * 1996-08-26 1998-03-05 Genetics Institute, Inc. Inhibitors of phospholipase enzymes
ID27280A (id) * 1998-02-25 2001-03-22 Genetics Inst Inhibitor-inhibitor dari enzim-enzim fosfolipase
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
EP1316548A4 (en) * 2000-07-05 2004-05-19 Ajinomoto Kk ACYLSULFONAMIDE DERIVATIVES
DE10043790A1 (de) 2000-09-06 2002-03-14 Bayer Ag Substituierte 1-Aryl-pyridin-2-(thi)one
EP1339668A2 (en) 2000-11-28 2003-09-03 Guilford Pharmaceuticals Inc. Bisubstituted carbocyclic cyclophilin binding compounds and theirus
US6656971B2 (en) 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
US20040242456A1 (en) 2001-09-06 2004-12-02 Christoph Luthy Herbicidal n-alkysulfonamino derivatives
US6797708B2 (en) * 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
KR100973665B1 (ko) * 2001-12-03 2010-08-04 와이어쓰 엘엘씨 세포질 포스포리파제 ａ2의 억제제
US6635771B2 (en) * 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7101875B2 (en) 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US6984735B2 (en) 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
TW200510305A (en) 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
US7582771B2 (en) 2003-09-03 2009-09-01 Wyeth Process for the synthesis of cPLA2 inhibitors
US7342119B2 (en) 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) * 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles

Also Published As

Publication number Publication date
US7259277B2 (en) 2007-08-21
BRPI0412904A (pt) 2006-09-26
JP4607877B2 (ja) 2011-01-05
ATE432918T1 (de) 2009-06-15
EP1648861A1 (en) 2006-04-26
EP1648861B1 (en) 2009-06-03
US20050020858A1 (en) 2005-01-27
TW200510305A (en) 2005-03-16
AU2004261567A1 (en) 2005-02-10
CN1816522A (zh) 2006-08-09
CA2528174C (en) 2012-03-13
MXPA06000406A (es) 2006-03-17
US6891065B2 (en) 2005-05-10
US20050159613A1 (en) 2005-07-21
CA2528174A1 (en) 2005-02-10
JP2007500190A (ja) 2007-01-11
ES2325265T3 (es) 2009-08-31
DE602004021388D1 (de) 2009-07-16
WO2005012238A1 (en) 2005-02-10
CN100577640C (zh) 2010-01-06

Similar Documents

Publication Publication Date Title
AR045089A1 (es) "proceso para la preparacion de inhibidores de la cpla2"
AR054799A1 (es) Derivados de oxindol
EA200600351A1 (ru) Новые соединения, обладающие ингибирующей активностью в отношении натрийзависимого транспортёра
ES2570756T3 (es) Derivados pirimidinilpirrolopiridinona sustituidos, proceso para su preparación y su uso como inhibidores de cinasa
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR057894A1 (es) Derivados de tiofeno
AR055592A1 (es) Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace)
AR047456A1 (es) Derivados de amidas, procesos para su preparacion y uso como insecticidas
RS52978B (en) FUSIONED AMINO PIRIDIN AS HSP90 INHIBITORS
EA201490580A1 (ru) Пирролбензодиазепины и их конъюгаты
ECSP055815A (es) Composición para el tratamiento de la infección por virus flaviviridae
AR057023A1 (es) Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
UY28577A1 (es) Proceso químico e intermedios
HRP20080429T3 (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
AR055053A1 (es) Compuestos indol sustituidos con actividad inhibidora de nos. composiciones farmaceuticas.
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
AR056764A1 (es) Aminopirimidinas utiles como inhibidores de quinasa
ME00443B (me) Kristalni oblik tercijalne butilaminske soli perindoprila
JP2012522729A5 (es)
AR064319A1 (es) Compuestos y composiciones farmaceuticas derivadas de sulfonamida ciclicos, proceso de preparacion y usos en el tratamiento de trastornos vasomotrices, sexuales, gastrointestinales y otros
AR060489A1 (es) Derivados del acido benzoazepin - oxi- acetico como agonistas de ppar - delta usados para aumentar hdl- c, reducir ldl-c y reducir colesterol
AR057914A1 (es) Compuestos organicos de azufre y su uso
PE20030762A1 (es) Compuestos heterociclicos como antagonistas nk1
AR082864A2 (es) Preparacion de compuestos de aminopirimidina

Legal Events

Date Code Title Description
FB Suspension of granting procedure